Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04788329 · ClinicalTrials.gov registry record · NA

The Effect of Mindfulness Programs on Postoperative Pain

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT04788329: Completed NA study, sponsored by NYU Langone Health.

NCT04788329 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04788329, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

Participants undergoing hand surgery will be assessed and compared for postoperative pain. The patients' experience of going through surgery will be evaluated. The patient satisfaction and patient assessed outcomes will be measured.

Primary Outcome

Pain will be measured by the visual analog scale (VAS) scale, The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

Interventions

  • BEHAVIORAL "Prepare for Surgery, Heal Faster" Program
  • BEHAVIORAL Wim Hof Method

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2021-02-15
Est. Completion 2022-03-01
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT04788329 record still lists

NCT04788329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which "Prepare for Surgery, Heal Faster" Program is the first listed.

NCT04788329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04788329 about?

NCT04788329 is a clinical study titled "The Effect of Mindfulness Programs on Postoperative Pain". Participants undergoing hand surgery will be assessed and compared for postoperative pain. The patients' experience of going through surgery will be evaluated. The patient satisfaction and patient assessed outcomes will be measured.

What is the current status of trial NCT04788329?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-02-15. Estimated completion is 2022-03-01.

What interventions are being tested in trial NCT04788329?

The interventions under investigation include: "Prepare for Surgery, Heal Faster" Program (BEHAVIORAL), Wim Hof Method (BEHAVIORAL).

Who is sponsoring clinical trial NCT04788329?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04788329's enrollment target sits among peer trials

23 1755th of 2000 higher than 245 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04788329, the US trial registry maintained by the National Library of Medicine. NCT04788329 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.